Overview
Updated 14 Jul 2026
Carl June, MD, is Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine at University of Pennsylvania, Perelman School of Medicine. The public record shows 1,422 publications with 148,784 citations (h-index 179), centered on CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 11 companies, 19 NIH-funded awards (2004–2026).
- Most recent indexed publication: 2026 · The New England journal of medicine
- Top research focus: CAR-T cell therapy research
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 106 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 656.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy
Sponsor: University of Pennsylvania
InvestigatorPhase 1CompletedNCT02374333 - Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma
Sponsor: University of Pennsylvania
InvestigatorPhase 1CompletedNCT00834665
Industry payments
Updated 14 Jul 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment$8,978,680openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Gilead Sciences, Inc.Program year20252 payments
NIH funding
Updated 14 Jul 2026
19 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
University of Pennsylvania
FY2026$4,316,508U01AI163087 - Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
University of Pennsylvania
FY2025$4,303,502U01AI163087 - Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
University of Pennsylvania
FY2025$2,863,199P01CA214278
Congress activity
Updated 14 Jul 2026
113 congress contributions (2005–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Abstract 4806: CAR binders affect CAR T cell tonic signaling, durability, and sensitivity to target
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.
The New England journal of medicine
2026 - Kidney Transplantation in Two Highly Sensitized Candidates after CAR T-Cell Therapy.
The New England journal of medicine
2026
Most-cited worksby citation count (OpenAlex)
- 01
- 02Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia5,419 citations2014
- 03Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia3,545 citations2011
- 04Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia3,498 citations2013
- 05Cytokine Storm3,186 citations2020
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
3400 Civic Center Blvd, STRC 421 8-123, Philadelphia, PA 19104-5156
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗
- Board Certified
Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗ - Board Certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
Editorial & leadership rolesjournal and society appointments
- Director
Center for Cellular Immunotherapies, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Director
Parker Institute for Cancer Immunotherapy, Penn Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkerici.org ↗ - Member
American Philosophical Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.upenn.edu ↗
Secondary affiliationsappointments beyond the home institution
- Professor of Medicine
Perelman School of Medicine, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pathology.med.upenn.edu ↗ - Director
Parker Institute for Cancer Immunotherapy at Penn
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →parkerici.org ↗
Media & interviewspress, podcasts and appearances
- "From CAR T-Cell Therapy to the Impact of Mentorship with Carl June, MD"
From Bench to Fireside podcast
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →usnews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/carl-june-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/carl-june-69402823b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Carl-June
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/university-of-pennsylvania-health-system_carl-june-breakthrough-prize-2024-activity-7108078082413977600-RB6B
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/university-of-pennsylvania-health-system_dr-carl-june-pioneer-in-car-t-cell-immunotherapy-activity-7162932301629227008-ZHAv
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/posts/university-of-pennsylvania_carl-june-on-the-boundless-potential-of-car-activity-7103772316152553472-wTY1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Callans, MD
University of Pennsylvania
- 767
- publications
- 96
- h-index
- 7
- trials
Stephen Schuster, MD
University of Pennsylvania
- 804
- publications
- 77
- h-index
- 11
- trials
Kenneth Margulies, MD
University of Pennsylvania
- 605
- publications
- 89
- h-index
- 2
- trials
Bonnie Ky, MD
University of Pennsylvania
- 470
- publications
- 72
- h-index
- 12
- trials